Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,126
Closed -$275K 487
2025
Q2
$275K Sell
2,126
-110
-5% -$13.3K 0.02% 377
2025
Q1
$267K Buy
2,236
+81
+4% +$10K 0.02% 383
2024
Q4
$250K Buy
2,155
+25
+1% +$3.16K 0.02% 364
2024
Q3
$287K Sell
2,130
-24
-1% -$3.21K 0.02% 327
2024
Q2
$292K Sell
2,154
-34
-2% -$4.63K 0.02% 318
2024
Q1
$283K Sell
2,188
-168
-7% -$20.3K 0.02% 348
2023
Q4
$269K Sell
2,356
-184
-7% -$18.4K 0.02% 385
2023
Q3
$231K Sell
2,540
-170
-6% -$17.5K 0.02% 401
2023
Q2
$305K Sell
2,710
-62
-2% -$6.56K 0.02% 383
2023
Q1
$290K Sell
2,772
-94
-3% -$9.82K 0.02% 398
2022
Q4
$317K Buy
2,866
+22
+0.8% +$2.31K 0.03% 368
2022
Q3
$248K Buy
+2,844
New +$258K 0.02% 395
2022
Q2
Sell
-2,143
Closed -$257K 528
2022
Q1
$257K Hold
2,143
0.02% 408
2021
Q4
$257K Buy
2,143
+251
+13% +$31.2K 0.02% 408
2021
Q3
$234K Buy
1,892
+85
+5% +$10.9K 0.02% 378
2021
Q2
$217K Sell
1,807
-127
-7% -$14.5K 0.02% 381
2021
Q1
$203K Buy
+1,934
New +$196K 0.02% 363

Other funds holding XYL

Clarius Group LLC's XYL Position: Q3 2025 in Review

Clarius Group LLC sold out of Xylem (XYL) in Q3 2025, closing a stake of 2,126 shares — an estimated $275K sold.

Clarius Group LLC first reported a position in XYL in Q1 2021 and held it in 17 quarters. The position peaked at $317K in Q4 2022. 1,084 funds tracked by Wall St. Rank hold XYL as of Q3 2025.

  • Clarius Group LLC reported no remaining Xylem position as of Q3 2025 after selling out during the quarter.
  • Clarius Group LLC sold 2,126 Xylem shares in Q3 2025, an estimated $275K.
  • Clarius Group LLC first reported a position in Xylem in Q1 2021 and held it in 17 quarters.
  • Clarius Group LLC's Xylem position peaked at $317K in Q4 2022.
  • 1,084 funds tracked by Wall St. Rank held Xylem as of Q3 2025.

Based on Clarius Group LLC's 13F filing for Q3 2025, filed 14 Oct 2025.